P. Bedossa

Ela fi branor , an Agonist of the Peroxisome Proliferator L Activated Receptor L a and L d , Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

P. Bedossa, J. Drenth, A. Sanyal, 2022 .

Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.

K. Lucas, R. Shringarpure, Erik J. Tillman, 2023, The lancet. Gastroenterology & hepatology.

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

N. Lanthier, M. Abdelmalek, Q. Anstee, 2024, The New England journal of medicine.